Monoclonal Anti-PEG Antibody, Mouse IgG1 (5G3-1C6)

Cat. No. / Size
Price
Availability
Qty
PEG-M687-100ug
$355.00
In Stock - Delivery in 1-2 business days
PEG-M687
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Monoclonal Anti-PEG Antibody, Mouse IgG1 (5G3-1C6) is a recombinant mouse monoclonal antibody expressed in HEK293 cells.

Antibody Type

Recombinant Monoclonal

Clone

5G3-1C6

Isotype

Mouse IgG1, Kappa

Host Species

Mouse

Reactivity

Chemical

Immunogen

PEG

Specificity

Specifically recognizes PEG.

Application
Application
Recommended Use
ELISA
0.2-2 μg/mL
MSD
Suitable and internally validated for detecting anti PEG antibodies

* Recommended dilutions are for reference only. Optimal working concentrations may vary depending on your consumables, reagents, and assay conditions. We recommend optimizing for your specific system. No warranty is made regarding performance at any specific dilution.

Purification

Protein A purified.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

Background

Polyethylene glycol (PEG) is a synthetic polymer widely used in pharmaceuticals as a stabilizer and excipient. PEGylation—the attachment of PEG chains to proteins or drugs—improves solubility, prolongs circulation half life, and reduces immunogenicity. Several PEGylated therapeutics, such as PEG interferon and PEG filgrastim, are already in clinical use. However, anti PEG antibodies may affect drug efficacy, making reliable detection tools essential for research and quality control.